In fact, a study in 2004 demonstrated that the HLA-DRB*15:03 allele, which occurs almost exclusively in individuals of African descent, confers moderate risk to MS in African American individuals but no measurable risk in other populations [11, 12]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.